Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells

Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune Cells

The identification of transcriptomic alterations of HER2+ ductal carcinoma in situ (DCIS) that are associated with the density of tumor-infiltrating lymphocytes (TILs) could contribute to optimizing choices regarding the potential benefit of immune therapy. We compared the gene expression profile of...

Full description

Bibliographic Details
Main Authors: Marie Colombe Agahozo, Marcel Smid, Ronald van Marion, Dora Hammerl, Thierry P. P. van den Bosch, Mieke A. M. Timmermans, Chayenne J. Heijerman, Pieter J. Westenend, Reno Debets, John W. M. Martens, Carolien H. M. van Deurzen
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Biology
Subjects:
breast ductal carcinoma in situ
HER2 amplification
transcriptome assay
next generation sequencing
RNA
protein
Online Access:https://www.mdpi.com/2079-7737/10/8/768

Internet

https://www.mdpi.com/2079-7737/10/8/768

Similar Items